How should I evaluate a patient with elevated testosterone levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Elevated Testosterone

When testosterone is elevated above twice the upper limit of normal, immediately measure DHEAS to differentiate between adrenal and ovarian sources of androgen excess 1.

Initial Assessment

Confirm the Elevation

  • Repeat the testosterone measurement in the early follicular phase (if menstruating) using a reliable assay, ideally liquid chromatography-tandem mass spectrometry (LC-MS/MS) 2
  • Ensure fasting morning sample to minimize biological variation
  • Critical pitfall: Heterophile antibodies can cause falsely elevated testosterone on immunoassays 3, 4. If clinical presentation doesn't match the lab value (e.g., very high testosterone without virilization), suspect assay interference and confirm with LC-MS/MS

Review Medications and Conditions

Before proceeding with extensive workup, verify:

  • Medications that increase SHBG: thyroid hormones, tamoxifen, raloxifene, Op'DDD, or antiepileptic agents (e.g., valproate) can elevate total testosterone without true hyperandrogenism 1
  • Hyperthyroidism or liver disease (especially cirrhosis with portal hypertension) can markedly elevate SHBG 1

Algorithmic Approach Based on Testosterone Level

If Testosterone ≥2× Upper Limit of Normal

Measure DHEAS immediately 1:

If DHEAS >600 µg/dL (16,000 nmol/L):

  • Indicates adrenal cortical adenoma (often with hypercorticism)
  • Obtain abdominal CT scan urgently 1

If DHEAS is normal:

  • Suspect ovarian source: either ovarian hyperthecosis or androgen-secreting ovarian tumor
  • Both conditions show LH-dependent testosterone elevation
  • Consider transvaginal ultrasound to evaluate ovaries
  • Clinical clue: Ovarian hyperthecosis typically associates with insulin resistance 1

Additional Diagnostic Tests

Measure SHBG 1:

  • Reduced in obesity, metabolic syndrome, or family history of diabetes
  • Allows calculation of free or non-SHBG bound testosterone
  • Helps interpret total testosterone levels accurately

Consider 17-hydroxyprogesterone (17-OHP) 1:

  • To screen for nonclassic 21-hydroxylase deficiency
  • Particularly important if PCOS suspected with irregular cycles and pronounced hirsutism

Optional: Δ4-androstenedione 1:

  • May be elevated when testosterone is normal, especially with reduced SHBG
  • Useful when clinical hyperandrogenism exists despite normal testosterone

Tumor Screening Thresholds

Important caveat: While testosterone >8.7 nmol/L (250 ng/dL) has been proposed as a screening threshold for androgen-secreting neoplasms, the positive predictive value is only 9% 5. Clinical presentation matters more than absolute values—rapidly progressive virilization demands urgent investigation regardless of specific testosterone level.

Testosterone/Androstenedione ratio can help differentiate:

  • Ratio >1.5 suggests ovarian androgen-secreting tumor or hyperthecosis 6
  • Ratio approaching 1.0 suggests polycystic ovarian disease 6

Key Clinical Pearls

  • Rapidly progressive virilization (deepening voice, clitoromegaly, male-pattern baldness) demands urgent tumor workup even if testosterone is only moderately elevated
  • Postmenopausal women with any significant testosterone elevation warrant more aggressive investigation
  • Asymptomatic patients with isolated lab elevation should have assay interference excluded before extensive imaging 3, 4
  • Normal testosterone with clear hyperandrogenic symptoms (hirsutism, acne) requires measurement of free testosterone and SHBG to unmask hyperandrogenism 1

References

Guideline

recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Research

Accurate measurement of total and free testosterone levels for the diagnosis of androgen disorders.

Best practice & research. Clinical endocrinology & metabolism, 2022

Research

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.